Health3 years ago
Early Monoclonal Antibody Treatment of COVID-19 Beneficial for High-Risk COVID-19 Patients
Sotrovimab (GlaxoSmithKline), a monoclonal antibody, appears to reduce the risk of progression in mild to moderate cases of COVID-19 in patients at high risk of progression,...
Recent Comments